>중동 및 아프리카 임상 검사 서비스 시장, 전문 분야별(임상 화학 검사, 혈액학 검사, 미생물학 검사 , 면역학 검사, 약물 남용 검사, 세포학 검사 및 유전자 검사 ), 공급업체(독립 및 참조 실험실, 병원 기반 실험실 및 간호 및 의사 사무실 기반 실험실), 응용 분야(신약 발견 관련 서비스, 약물 개발 관련 서비스, 생물 분석 및 실험실 화학 서비스, 독성학 검사 서비스, 세포 및 유전자 치료 관련 서비스, 전임상 및 임상 시험 관련 서비스 및 기타 임상 검사 서비스), 서비스 유형(일상 검사 서비스, 난해한 서비스 및 해부 병리학 서비스), 국가(브라질, 아르헨티나, 남미 기타 지역, 남아프리카 공화국, 사우디 아라비아, UAE, 이집트, 이스라엘 및 중동 및 아프리카 기타 지역) 산업 동향 및 2028년까지의 예측.
시장 분석 및 통찰력: 중동 및 아프리카 임상 실험실 서비스 시장
임상 검사 서비스 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 4.7%의 CAGR로 성장하고 있으며 2028년까지 7,551.56백만 달러에 도달할 것으로 예상된다고 분석합니다. 전 세계적으로 증가하는 감염병 과 임상 진단 방법의 발전은 중동 및 아프리카 임상 검사 서비스 시장 성장을 견인하는 원동력으로 작용합니다.
임상 실험실은 의료 분야의 중요한 부분입니다. 혈액 검사에서 유전자 분석에 이르기까지 대부분의 진단 검사는 이러한 임상 실험실에서 다양한 질병을 탐지하기 위해 수행됩니다. 임상 실험실은 진단 및 검사 결과와 같이 의료 시스템에서 필요한 분배를 최적화하는 데 도움이 되는 데이터와 리소스를 제공합니다. 이를 통해 의사가 다양한 수준의 의료 서비스에서 적절한 임상 및 진단 결정을 내릴 수 있도록 하는 신뢰할 수 있고 정확한 검사 결과를 유지하고 제공합니다. 이를 통해 임상의는 의료 실험실 시설이 없다면 방해받을 수 있는 치료를 적응, 시작하고 중단할 수 있습니다. 임상 실험실 서비스에는 약물 발견, 약물 개발, 생물 분석 및 실험실 화학, 독성학 검사, 세포 및 유전자 치료 , 임상 전 및 임상 시험 관련 서비스가 포함됩니다. 독립 및 참조 실험실, 병원 기반 실험실, 간호 및 의사 사무실 기반 실험실은 임상 실험실 서비스의 주요 제공자 중 일부입니다.
중동 및 아프리카 임상 검사 서비스 시장의 성장은 감염성 질환 발생 증가와 조기 및 정확한 질병 진단에 대한 수요 증가, 임상 진단 방법의 발전을 반영합니다. 또한, 향후 중동 및 아프리카 임상 검사 서비스 시장 성장에 기여할 것으로 예상되는 주요 요인은 디지털 병리학 플랫폼 채택 증가, 임상 검사실에서 제공하는 종합 건강 검진 선호도입니다. 부적절한 환불 정책과 함께 부정확한 검사 결과는 중동 및 아프리카 임상 검사 서비스 시장 성장을 제한할 것으로 예상됩니다. 그러나 의료 서비스 지불자와 제공자가 직면한 가격 압박과 가정 기반/진료 시점 검사 절차에 대한 선호도 증가는 시장 성장을 방해할 것으로 예상됩니다.
임상 검사 서비스 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 임상 검사 서비스 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
임상실험실 서비스 시장 범위 및 시장 규모
임상 검사 서비스 시장은 전문 분야, 공급자, 응용 프로그램 및 서비스 유형으로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- 전문성에 따라 시장은 임상 화학 검사, 혈액학 검사, 미생물학 검사, 면역학 검사, 약물 남용 검사, 세포학 검사 및 유전자 검사로 세분화됩니다. 2021년에는 임상 화학 검사 부문이 시장을 지배할 것으로 예상되는데, 질병의 빠른 진단에 사용되는 진료소 검사 솔루션에 대한 수요가 증가함에 따라 시장이 크게 성장할 것으로 예상됩니다.
- 공급자를 기준으로 시장은 독립 및 참조 실험실, 병원 기반 실험실, 간호 및 의사 사무실 기반 실험실로 세분화됩니다. 2021년에는 병원 기반 실험실 부문이 병원에서 부상 사례가 증가하여 환자 수가 많아져 시장을 지배할 것으로 예상됩니다.
- On the basis of application, the market is segmented into drug discovery related services, drug development related services, bioanalytical & lab chemistry services, toxicology testing services, cell & gene therapy related services, preclinical & clinical trial related services and other clinical laboratory services. In 2021, the bioanalytical & lab chemistry services segment is expected to dominate the market because lab chemistry services provide support in the chemical analysis including elemental analysis, failure analysis and project analysis.
- On the basis of service type, the market is segmented into routine testing services, esoteric services and anatomic pathology services. In 2021, the routine testing services segment is expected to dominate the market due to increasing demand of research and development.
Clinical Laboratory Services Market Country Level Analysis
The clinical laboratory services market is analyzed and market size information is provided by the country specialty, provider, application and service type as referenced above.
The countries covered in the clinical laboratory services market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.
South Africa is expected to dominate the clinical laboratory services market due to increasing awareness about diagnosis and treatment of the disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Clinical Laboratory Services is Boosting the Market Growth of Clinical Laboratory Services Market
The clinical laboratory services market also provides with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010-2019.
Competitive Landscape and Clinical Laboratory Services Market Share Analysis
임상 검사 서비스 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 임상 검사 서비스 시장과 관련된 회사의 초점에만 관련이 있습니다.
임상 검사 서비스를 취급하는 주요 기업으로는 Mayo Foundation for Medical Education and Research(MFMER), UNILABS, ACM Middle East and Africa Laboratories, Abbott 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 회사에서 많은 계약, 협정, 협업 및 출시가 시작되면서 임상 검사 서비스 시장도 가속화되고 있습니다.
예를 들어,
- 2021년 7월, 인공지능(AI) 암 진단 분야의 선도 기업인 Deep Bio는 혁신적인 실험실 연구 및 개발 분야의 세계적 리더이자 미국 최고의 기준 실험실인 ARUP Laboratories와 연구 협력 계약을 체결했다고 발표했습니다. 이 협력은 암 진단에 인공지능을 사용하는 측면에서 회사에 이점이 되었습니다.
제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략을 통해 임상 검사 서비스 시장에서 회사의 입지가 강화되고 있으며, 이는 조직의 수익 성장에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 OVERVIEW OF ADJACENT BUSINESS
5.1 IMPACT OF POINT OF CARE TESTING MARKET ON CLINICAL LABORATORY TESTING MARKET
5.2 IMPACT OF BIOMETRIC SCREENING MARKET ON CLINICAL LABORATORY TESTING MARKET
5.3 IMPACT OF MOLECULAR DIAGNOSTICS MARKET ON CLINICAL LABORATORY TESTING MARKET
5.4 CONCLUSION
6 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATIONS IN THAILAND
6.4 REGULATIONS IN DUBAI
6.5 REGULATIONS IN INDIA
6.6 REGULATIONS IN CHINA
6.7 REGULATIONS IN JAPAN
6.8 REGULATIONS IN SOUTH AFRICA
7 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: REIMBURSEMENTS
7.1 REIMBURSEMENT IN THE U.S. FOR CLINICAL LABORATORY SERVICES
7.2 REIMBURSEMENT IN INDIA FOR CLINICAL LABORATORY SERVICES
7.3 REIMBURSEMENT IN JAPAN FOR CLINICAL LABORATORY SERVICES
7.4 REIMBURSEMENT IN EUROPE FOR CLINICAL LABORATORY SERVICES
7.5 REIMBURSEMENT IN SOUTH AFRICA FOR CLINICAL LABORATORY SERVICES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISE IN INFECTIOUS DISEASES WORLDWIDE
8.1.2 ADVANCEMENT IN CLINICAL DIAGNOSTIC METHODS
8.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
8.1.4 RISE IN DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS
8.1.5 INCREASE IN APPLICATION OF HIGH-THROUGHPUT ASSAYS
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 STRICT REGULATORY POLICIES
8.3 OPPORTUNITIES
8.3.1 INCREASE IN ADOPTION OF DIGITAL PATHOLOGY PLATFORMS
8.3.2 RISE IN PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
8.3.3 INCREASE IN AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
8.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.4 CHALLENGES
8.4.1 INACCURATE RESULTS OF TESTS
8.4.2 INADEQUATE REIMBURSEMENTS POLICIES
9 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
9.1 PRICE IMPACT
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY CHAIN
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
10.1 OVERVIEW
10.2 ROUTINE TESTING SERVICES
10.2.1 ROUTINE CHEMISTRY TESTING
10.2.2 ROUTINE HEMATOLOGY TESTING
10.2.3 URINALYSIS TESTING
10.2.4 SUBSTANCE ABUSE TESTING
10.2.5 OTHERS
10.3 ESOTERIC SERVICES
10.4 ANATOMIC PATHOLOGY SERVICES
10.4.1 CYTOLOGY TESTING
10.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING
10.4.3 AUTOPSY PATHOLOGY
10.4.4 OTHERS
11 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
11.1 OVERVIEW
11.2 CLINICAL CHEMISTRY TESTING
11.2.1 ROUTINE CHEMISTRY TESTING
11.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING
11.2.3 SPECIALIZED CHEMISTRY TESTING
11.2.4 OTHER CLINICAL CHEMISTRY TESTING
11.3 HEMATOLOGY TESTING
11.3.1 ROUTINE HEMATOLOGY TESTING
11.3.2 SPECIALIZED HEMATOLOGY TESTING
11.3.3 COAGULATION TESTING
11.4 MICROBIOLOGY TESTING
11.4.1 INFECTIOUS DISEASE TESTING
11.4.2 TRANSPLANT DIAGNOSTIC TESTING
11.4.3 OTHER MICROBIOLOGY TESTING
11.5 IMMUNOLOGY TESTING
11.6 DRUGS OF ABUSE TESTING
11.7 CYTOLOGY TESTING
11.8 GENETIC TESTING
12 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
12.1 OVERVIEW
12.2 HOSPITAL-BASED LABORATORIES
12.3 INDEPENDENT & REFERENCE LABORATORIES
12.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES
13 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES
13.3 DRUG DEVELOPMENT RELATED SERVICES
13.4 DRUG DISCOVERY RELATED SERVICES
13.5 TOXICOLOGY TESTING SERVICES
13.6 CELL & GENE THERAPY RELATED SERVICES
13.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES
13.8 OTHER CLINICAL LABORATORY SERVICES
14 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY REGION
14.1 MIDDLE EAST & AFRICA
14.1.1 SOUTH AFRICA
14.1.2 SAUDI ARABIA
14.1.3 U.A.E.
14.1.4 EGYPT
14.1.5 ISRAEL
14.1.6 REST OF MIDDLE EAST & AFRICA
15 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 LABORATORY CORPORATION OF AMERICA
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 SERVICE PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
17.2.1 COMPANY SNAPSHOT
17.2.2 COMPANY SHARE ANALYSIS
17.2.3 SERVICE PORTFOLIO
18.1.1 RECENT DEVELOPMENTS
18.2 DAVITA INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 SERVICE PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 QUEST DIAGNOSTICS INCORPORATED
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 SERVICE PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 SONIC HEALTHCARE
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 SERVICE PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 ABBOTT
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENTS
18.6 ACM MIDDLE EAST & AFRICA LABORATORIES
18.6.1 COMPANY SNAPSHOT
18.6.2 SERVICE PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 AMEDES HOLDING GMBH
18.7.1 COMPANY SNAPSHOT
18.7.2 SERVICE PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ARUP LABORATORIES
18.8.1 COMPANY SNAPSHOT
18.8.2 SERVICE PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 BIOREFERENCE LABORATORIES, INC. (A SUBSIDIARY OF OPKO HEALTH, INC.)
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 SERVICE PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 CHARLES RIVER
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 SERVICE PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 EUROFINS SCIENTIFIC
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 SERVICE PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 GENOMIC HEALTH
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 H.U. GROUP HOLDINGS, INC.
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 SERVICE PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 KINGMED DIAGNOSTICS
18.14.1 COMPANY SNAPSHOT
18.14.2 SERVICE PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 LIFELABS
18.15.1 COMPANY SNAPSHOT
18.15.2 SERVICE PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 NEOGENOMICS LABORATORIES, INC.
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 SERVICE PORTFOLIO
18.16.4 RECENT DEVELOPMENTS
18.17 SIEMENS HEALTHINEERS GMBH
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 SERVICE PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 ,SYNLAB INTERNATIONAL GMBH (A SUBSIDIARY OF SYNLAB AG)
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 SERVICE PORTFOLIO
18.18.4 RECENT DEVELOPMENTS
18.19 NILABS
18.19.1 COMPANY SNAPSHOT
18.19.2 SERVICE PORTFOLIO
18.19.3 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
표 목록
LIST OF TABLES
TABLE 1 NUMBER OF CORONAVIRUS (COVID-19) TESTS PERFORMED IN THE MOST IMPACTED COUNTRIES WORLDWIDE AS OF JULY 27, 2021
TABLE 2 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS
TABLE 3 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA ESOTERIC SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA IMMUNOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA CYTOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HOSPITAL-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA INDEPENDENT AND REFERENCE LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA BIOANALYTICAL AND LAB CHEMISTRY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA DRUG DEVELOPMENT RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA DRUG DISCOVERY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA TOXICOLOGY TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CELL AND GENE THERAPY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA PRECLINICAL AND CLINICAL TRIAL RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA OTHER CLINICAL LABORATORY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 71 EGYPT ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 72 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 73 EGYPT CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 74 EGYPT MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 75 EGYPT HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 76 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 77 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 84 ISRAEL HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 85 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 86 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 REST OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
그림 목록
LIST OF FIGURES
FIGURE 1 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 11 RISING INFECTIOUS DISEASES WORLDWIDE AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
FIGURE 15 BELOW ARE BENEFITS THAT HAVE TO INCREASE THE ADOPTION OF DIGITAL PATHOLOGY PLATFORMS:
FIGURE 16 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020
FIGURE 17 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020
FIGURE 21 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020
FIGURE 25 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, CAGR (2020-2028)
FIGURE 27 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020
FIGURE 29 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 31 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SNAPSHOT (2020)
FIGURE 33 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020)
FIGURE 34 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 35 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 36 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE (2021 & 2028)
FIGURE 37 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
